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ABSTRACT The livR gene encoding the repres- 
sor for high-affinity branched-chain amino acid 
transport in Escherichia coli has been cloned from a 
library prepared from the episome F106. The inserted 
DNA fragment from the initial cloned plasmid, 
pANT1, complemented two independent, sponta- 
neously derived, regulatory mutations. Subcloning 
as well as the creation of deletions with Ba131 exo- 
nuclease revealed that the entire regulatory region 
is contained within a 1.1-kb RsaI-SalI fragment. 
Expression of the PANT plasmids in E. coli minicells 
showed that the regulatory region encodes one de- 
tectable protein with an apparent molecular weight 
of 21,000. DNA sequencing revealed one open reading 
frame of 501 bp encoding a protein with a calculated 
MW of 19,155. The potential secondary structure of 
the regulatory protein has been predicted and i t  sug- 
gests that the carboxy terminus may fold into three 
consecutive alpha helices. These results suggest that 
the livR gene encodes a repressor which plays a role 
in the regulation of expression of the livJ and the 
ZiuK transport genes. 
Key words: regulation, prokaryotic bacteria, leu- 
cine uptake, leucyl tRNA corepressor, 
cell physiology 
INTRODUCTION 
Branched-chain amino acid transport in Esche 
richia coli is carried out by three distinct transport 
systems. The system designated LIV-I transports the 
L-isomers of leucine, isoleucine, and valine with a 
high affinity and threonine and alanine with a some- 
what lower affinity.' The leucine-specific (LS) trans- 
port system transports primarily the D- and L-isomers 
of leucine with relatively high affinity.' These two 
high-afhity systems are regulated in response to the 
intracellular levels of leucine. The third transport 
system, LIV-11, operates with a low affinity for leu- 
cine, isoleucine, and valine and is not significantly 
regulated by any of the branchedchain amino acids? 
The LIV-I and LS transport systems have been ge- 
netically mapped to minute 76 on the E. coli chromo- 
The genes encoding the protein components 
of these two transport systems have been cloned: and 
it appears that five proteins are required to effect 
transport. The LivH, LivM, and LivG proteins are 
components of both the LIV-1 and LS transport sys- 
tems, and these components appear to be associated 
0 1986 ALAN R. LISS, INC. 
with the inner The livK gene product 
(LS-BP) is a peripIasmic binding protein component 
of the LS system that utilizes both the D- and L- 
isomers of leucine as substrates. The 1ivK gene is the 
first gene of an operon which includes the livH, livM, 
and livG genes in that order.lO," The LIV-I transport 
system utilizes a periplasmic binding protein (LIV- 
BP) encoded by the l i d  gene." The livJ gene is 
transcribed from a monocistronic operon and, to- 
gether with the liuH, livG, and livM genes, encodes 
the components of the LIV-I transport system.'O,'l 
A previous report2 described two strains of E. coli, 
each harboring an independent, spontaneous regula- 
tory mutation for branched-chain amino acid trans- 
port. Each of these mutant strains exhibited 
derepressed rates of L-leucine transport, even in the 
presence of high concentrations of leucine. One of 
these mutations, livR, affected both the LIV-I and LS 
transport systems, whereas the lstR mutation af- 
fected primarily the LS transport system. The livR 
and lstR mutations are closely linked at minute 20 
on the E. coli chrom~some .~~  Since these regulatory 
loci are unlinked to the transport genes, it was de- 
duced that they encode a diffusible regulatory com- 
ponent. Further studies showed that the episome F106 
complements each mutation by restoring leucine reg- 
ulation of LIV-I and LS t ran~port . '~  
In order to determine the number and nature of the 
regulatory gene(s) for the LIV-I and LS transport 
systems, a DNA library in plasmid pBR322 was con- 
structed from the partially digested episome F106 
and a single clone containing the regulatory region 
was identified. This article describes the characteriza- 
tion and expression of the regulatory gene for 
branched-chain amino acid transport. 
MATERIALS AND METHODS 
Bacterial Strains 
The E. coli strain DH-1 ([F-,A-] recAl, endAl ,  
gyrA96, thi-1, hsdR17 [rk-, mk+], supE44,) was used 
for all initital recombinant plasmid constructions. 
Strains AE62, AE68(liuR), AE79 (ZZuR, leu), and 
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AE117 (IstR, leu, dlu) were described previo~sly. '~ 
The E.coli minicell-producing strain X1411 (minAl, 
minB2, supE42) was a gift from Dr. R. Helling of the 
University of Michigan. Strain JM10114 was used in 
DNA sequencing. 
Materials 
MOPS (morpholinopropane sulfonic acid), nutri- 
tional supplements, y<methacryloxy>propyltrime- 
thoxysilane (M-6514), and the Dalton Mark VI 
molecular weight markers for denaturing polyacryl- 
amide gel electrophoresis were purchased from the 
Sigma Company. Aqua-Sil was from the Pierce 
Chemical Company and the DNA Grade Bio-Gel HTP 
was from BioRad Laboratories. Bactotryptone, bacto- 
agar, and yeast extract were products of the Difco 
Company, Detroit, Michigan. Restriction enzymes, 
M13 phage, X-gal, and isopropylthio-P-D-galactoside 
were obtained from Betheseda Research Laborato- 
ries. The T4 DNA ligase was from International Bio- 
technologies, Inc. and the calf intestine alkaline 
phosphatase was obtained from the Boehringer 
Mannheim Company of W. Germany. The L-[3H]-leu- 
cine, L-[35S]-methionine, CI-[~~S]-~ATP, Y-[~~S]ATP, 
Klenow polymerase, T4 polynucleotide kinase, M13 
universal primer, and ColonyPlaque Screen hybrid- 
ization transfer membrane were from New England 
Nuclear. The source of all nonradioactive dideoxy- 
and deoxynucleotides was Pharmacia P-L Biochem- 
icals. 
Media 
Standard LB mediai5 supplemented as required 
with thymine (50 pg/ml) or ampicillin (30 pg/ml) was 
used to select transformants. For transport assays, 
Vogel-Bonner (VB) minimal mediai6 was used and 
supplemented with L-leucine at 25 pglml when indi- 
cated. Growth of minicells was done in MOPS rich 
media.17 For incorporation of L-[35S]-methionine, 
MOPS-rich media without methionine was used. 
Strain JMlOl was grown on 2xYT media or M9 
minimal media which were made as described 
pre~iously. '~ 
Transport Assays 
Cells were grown in 1-ml cultures overnight at 37°C 
in VB media. For strains AE62 (control) and AE68 
(ZiuR), cultures were grown with and without 25 pgl 
ml L-Ieucine. Strain AE117 (IStR) was a Ieucine aux- 
otroph and consequently was always grown in VB 
media supplemented with leucine. If the cells were 
harboring plasmids, ampicillin was included to select 
for retention of the plasmids. The overnight cultures 
were used to inoculate 4-ml cultures (1:lO dilution) 
which were grown to mid-log phase (OD420 = 0.4- 
0.7). The cells were washed and resuspended in ice- 
cold, unsupplemented VB media so that their final 
OD420 was between 0.4 and 0.8. Tubes containing 0.4 
ml of VB media plus L-[3H]-leucine at a final concen- 
tration of 200 nM were equilibrated to 37°C. Then, 
0.4 ml of the cell culture (briefly equilibrated to 37°C) 
was mixed with the tritiated solution for 10 seconds, 
pipetted onto a hydrated 0.45-pm nitrocellulose filter, 
and immediately washed 2 x with 5 ml of prewarmed 
10 mM potassium phosphate buffer (pH 7.2) contain- 
ing 0.1 mM MgS04. Radioactivity was determined by 
using a Packard liquid scintillation counter and stan- 
dard scintillation cocktail. Leucine uptake was cal- 
culated as m o l e s  leucinelmidmg dry cell weight. 
Construction of Recombinant Plasmids 
The DNA from the episorne F106 was prepared by 
growing cells to stationary phase and gently lysing 
with an  SDS s01ution.l~ Two consecutive cesium chlo- 
ride-ethidium bromide gradient separations were car- 
ried out by the method of El-Gewely and Helling." 
The samples were then dialyzed against 4 liters of 10 
mM Tris-HC1 (pH= 8.O), 1 mM EDTA overnight. The 
F106 DNA was partially digested with EcoRI and the 
resulting fragments in the 3-10-kb range were puri- 
fied by using low-melting agaro~e . '~  This mixture of 
fragments was ligated at 12°C overnight with pBR322 
DNA which had been linearized with EcoRI and de- 
phosphorylated by standard procedures.15 The liga- 
tion reaction (approximately 0.5 pg of DNA) was 
transformed into DH-1 cells made competent by the 
protocol of D. Hanahan.20 Ampicillin was used to 
select for colonies carrying recombinant molecuIes. 
These colonies were then grown to late log phase and 
the plasmid DNA was isolated by the rapid boiling 
method and transformed into strain AE68 (liuR) made 
competent by CaCl2 treatment.15 Colonies resistant 
to ampicillin were tested by the transport assay de- 
scribed above carried out both in the presence and in 
the absence of leucine. 
Isolation of Minicells 
The minicell strain X1411 was rendered competent 
by the CaClz method described above and was trans- 
formed with plasmids pBR322 (control), pANT1- 
pANT4, and PANTS. These cells were then grown in 
1-ml cultures overnight at 37 "C in MOPS-rich media 
pIus ampicillin. CuItures of 250 ml were inoculated 
and grown until late log phase (OD600=0.8-1.0). Mini- 
cells were isolated by a combination of differential 
centrifugation and differential-rate sedimentation 
through two consecutive sucrose gradients as de- 
scribed previously.2' The minicells were then resus- 
pended in the appropriate volume to yield an  
OD600=0.5 per 400 pl. Aliquots of 400 pl were frozen 
with 10% (v:v) glycerol at  -70°C. The ratio of whole 
cells to minicells was less than a maximum of l:104. 
In order to radioactively label proteins produced by 
the minicells, an aliquot of the minicell preparation 
was thawed and the cells were pelleted a t  12,OOOg in 
a minicentrifuge for 5 minutes. The pellet was resus- 
pended in 100 p1 MOPS rich media without methio- 
nine. The cells were incubated for 20 minutes at 37°C 
in order to allow degradation of chromosome-encoded 
mRNAs carried over from the whole cells. One 
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hundred pCi of L-[35S]-methionine were added to the 
cells and incubation was continued for 45 minutes. 
The cells were lysed by mixing with SDS running 
buffer and by boiling for 3 minutes. Electrophoresis 
on SDS-polyacrylamide gels22 was carried out at 15 
W until the bromophenol blue had reached the bot- 
tom of the gel. The gel was fixed for 60 minutes in 
40% methanol/lO% HOAc and subsequently dried un- 
der vaccuum onto Whatman 3MM paper. Autoradiog- 
raphy was carried out at least 12 hours at room 
temperature without intensifying screens. 
Recombinant DNA Cloning and DNA 
Sequencing Strategies 
Two strategies were used to sequence the DNA 
containing the wild-type regulatory region for the 
LIV-I and LS transport systems. One strategy in- 
volved directional cloning of the 1.8-Sall-KpnI frag- 
ment from pANT3 (see Fig. 2) in both orientations 
into the M13 vectors mp18 and mp19. The resulting 
clones were designated mpANT5 and mpANT6 and 
were then used as templates for sequencing with the 
M13 universal primer. Additional primers were syn- 
thesized based on the early sequence results in order 
to “walk” into the 2-kb fragment. Approximately 400 
bp were sequenced by this method. 
The other strategy used to deduce the wild-type 
sequence was to “shotgun” clone the 1.8-SalI-KpnI 
fragment by digesting it with TaqI or with Sau3A 
and by ligating the resulting pieces to mpl0 or mpl l  
linearized with the restriction endonucleases AccI or 
BamHI, respectively. The majority of the regulatory 
region was sequenced from these clones. The remain- 
ing gaps in the sequence as well as the remaining 
unsequenced complementary strands were completed 
by utilizing synthesized oligonucleotides as primers. 
Chain Elongation Reactions and Electrophoresis 
The annealing of primer to template and the elon- 
gation reactions were carried out as described previ- 
0us1y.~~ The denaturing gels were 8% acrylamide with 
a buffer gradient ( 2 . 5 ~  at the bottom; 0 . 5 ~  at the 
top) and were prepared as described previ0usly2~ In 
addition, one gel plate was treated with Aqua-Sil, 
which repels the acrylamide gel, while the other plate 
was treated with the y-(methacryloxy)-propyltrime- 
thoxysilane, which covalently bonds the acrylamide 
gel to the g l a ~ s . 2 ~  The gels were electrophoresed at 
20 mA (constant) until the bromphenol blue or the 
xylene cyanol reached the bottom of the gel. At this 
point, the plates were separated and the gel (which is 
bonded to one of the plates) was soaked twice in a 
solution of 10% HOAc: 10% methanol for 15 minutes. 
The gel bonded to the glass plate was dried at 80°C 
for 1-2 hr and autoradiography was carried out for 
2 4 4 8  hr. 
Oligonucleotide Synthesis and Purification 
After the oligonucleotides were synthesized, 1 ml of 
fresh, cold concentrated ammonium hydroxide was 
added to 0.5 x volume recovered from the column and 
the mixture was incubated overnight at  55°C. The 
oligo mix was then lyophilized and resuspended in 
250 pl of 10 mM Tris-HC1, 1 mM NaEDTA (pH 8.0). 
Approximately 0 . 0 5 ~  volume was used in an end- 
labeling reaction with T4 polynucleotide kinase and 
Y-[~~S]ATP. The radioactively labeled oligonucleotide 
was subjected to chromatography on a 3-ml G-25 col- 
umn made in HzO. Fractions of 100 pl were collected 
and 10% of each fraction was mixed with 4 ml of 
liquid scintillant in order to quantitate its radioactiv- 
ity. The fractions containing the oligonucleotide were 
collected, pooled, and then used as primers in the 
DNA sequencing reactions. 
Computer Analysis of the DNA Sequence 
All analyses of the DNA sequences and secondary 
structure predictions were done by using an IBM PC- 
AT, a Hayes Smartmodem 1200, and the BioNet Com- 
puter Resource. 
RESULTS 
A DNA library was constructed as described in 
Materials and Methods and one of the cloned plas- 
mids, pANTl, was found to contain sequences that 
complemented the livR mutation. Figure 1 shows the 
transport activities for several strains grown in the 
absence and presence of 25 pglml leucine. Strain AE62 
is wild type with respect to regulation of leucine 
transport and demonstrates a four to five fold de- 
crease in the rate of leucine uptake when grown in 
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Fig. 1. Complementation of regulatory mutations by the plas- 
mid PANT1 . Strains were grown either in the absence (open bars) 
or presence (filled bars) of 25 pg/rnl leucine in minimal media. For 
strains AE79 and AE117, both leucine auxotrophs, open bars 
represent the strains grown with leucine and without plasmids, 
while the stippled bars represent the strains carrying the plasmid 
PANT1 grown with leucine. 
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Fig. 2. Construction of subclones from the plasmid pANTI. The top line shows the insert (4.0 kb) of 
pANTl and the following lines depict the inserts of the subclones. Abbreviations are as follows: E = EcoRI, 
S = Sall, N = Nrul, R = Rsal ,K = Kpn. The arrow under PANT9 indicates the extent and direction of deletion 
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Fig. 3. Complementation of the regulatory mutations by subclones of the plasmid pANT1. Part A shows 
the rates of leucine uptake for strain AE68 (livR) harboring the PANT subclones. Part B shows the rates of 
leucine uptake for strain AE117 (lstR) carrying the PANT subclones. 
constitutively derepressed rate of leucine transport; 
however, when this strain was transformed with the 
plasmid PANT1 and grown with leucine, the rate of 
leucine transport was repressed. In order to confirm 
this result, the plasmid PANT1 was transformed into 
strain AE79 (ZivR, leu). This strain shows a dere- 
pressed rate of leucine transport in the presence of 
leucine (open bar) which was significantly reduced 
when the plasmid PANT1 was present (stippled bar). 
To determine whether the inserted fragment of the 
plasmid PANT1 also complemented the lstR muta- 
tion, the plasmid was transformed into strain AE117 
(LstR, leu, dlu). Figure 1 shows the repression of leu- 
cine transport was achieved only when strain AE117 
grown with leucine was harboring the plasmid 
pANT1. These data indicate that the recombinant 
plasmid PANT1 contains DNA sequences which can 
genetically complement both the livR and lstR muta- 
tions; therefore the cloned DNA insert from PANT1 
encodes the regulatory component for branchedchain 
amino acid transport. 
Four subclones were constructed from the 4.0-kb 
insert of the plasmid PANT1 (Fig. 2). It was antici- 
pated that if multiple regulatory genes existed, the 
above strategy would permit them to be separated 
and identified with these subclones. The plasmid 
pANT2 contained the 3.5kb EcoRI-SalI fragment from 
PANT1 ligated to EcoRI-SalI double-digested pBR322. 
The plasmid pANT3 was constructed from the 2.7 kb 
NruI fragment of PANT1 ligated with NruI-linear- 
ized pBR322. The third subclone to be discussed at 
this point, pANT4, was made by ligating the 1.2-kb 
RsaI-NruI fragment from pANT3 to NruI-linearized 
pBR322. As presented in Figure 3,  the inserted frag- 
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Fig. 4. In vivo expresssion of the PANT plasmids in E. coli 
rninicells. This autoradiograph shows the proteins produced from 
E. coli minicells which have been separated by SDS-PAGE. The 
proteins have incorporated L-[35S]-methionine and each minicell 
sample carries a different plasmid. For each sample, one-half of 
the volume of one minicell aliquot was loaded onto the gel. Lane 
1, pBR322; lane 2, pANT3; lane 3, pANT4; lane 4, PANTS. 
ments of all three subclones complemented the ZiuR 
and the lstR mutations. These results strongly sug- 
gest that the regulatory region resides within the 1.1- 
kb SalI-RsaI fragment. 
The E. coli minicell strain X1411 was used with the 
plasmids pANT1-pANT4 and pBR322 (control) in an  
attempt to identify a potential gene product. Figure 4 
represents an  autoradiograph of two 15% SDS-poly- 
acrylamide gels used to separate the protein products 
from the minicell samples. Lane 1 shows the proteins 
encoded by the plasmid pBR322 as well as the back- 
ground products presumably from long-lived chromo- 
some-encoded mRNAs contained in the minicells. 
Lanes 2 and 3 correspond to products from minicell 
samples harboring the plasmids pANT3 and pANT4, 
respectively. Samples that contained the plasmids 
PANT1 or pANT2 had banding patterns identical to 
the one for the plasmid pANT3 (data not shown). In 
each lane, the only detectable band correlating with 
the presence of plasmids pANT1-pANT4 but not with 
the plasmid pBR322 was the protein of molecular 
weight 21,000, which is indicated by the arrow. 
It was observed that the expression of this protein 
from pANT4 was significantly and specifically less 
than that from the other plasmids (Fig. 4, lane 3). 
One possible explanation for this decreased expres- 
sion was that some of the DNA sequence required for 
the wild-type level of expression may have been de- 
leted during the construction of plasmid pANT4. It 
therefore seemed possible that the promoter region of 
the gene encoding the protein flanked the RsaI site 
used in the construction of the plasmid pANT4 and 
that the 3' end of the gene was near the SAlI site. 
Furthermore it could be deduced from its MW that 
the protein must be encoded by a gene approximately 
500-600 bp in length. Since it was possible that two 






























Fig. 5. Complementation of the regulatory mutations by the 
deletion plasmid PANTS. Strains AE62 and AE68 (livff) were 
grown either in the absence (open bars) or in the presence (filled 
bars) of 25 pglrnl leucine in minimal media. Strain AE117 (lsfff) is 
a leucine auxotroph, so it was grown either with leucine and 
without plasmid (open bar) or with leucine while harboring the 
plasmid PANT9 (stippled bar). 
ment, it could not yet be concluded that the protein 
of MW 21,000 was indeed the regulatory protein for 
leucine transport. 
In order to determine the location of the regulatory 
gene(s) within the 1.1-kb SalI-RsaI fragment, a dele- 
tion plasmid, PANTS, was prepared by linearizing the 
plasmid pANT3 at the KpnI site (See Fig. 2), digest- 
ing the DNA with Ba131 exonuclease, repairing the 
DNA ends with Klenow polymerase, and ligating the 
resulting partially deleted fragments. The plasmids 
were screened by SalI digestion, and the deletion 
plasmid pANT9, missing a total of 1.5-1.6 kb, was 
chosen for further experiments. It was estimated by 
restriction mapping that the plasmid pANT9 had lost 
the RsaI site as well as an additional 100 bp of DNA 
(data not shown). While a deletion of this size was 
expected to abolish expression of the gene encoding 
the protein of M W  21,000, it would not be expected to 
interfere with the expression of other genes located 
downstream. 
Figure 5 shows the rate of leucine uptake for strains 
AE68 (ZiuR) and AE117 (ZstR) harboring the plasmid 
pANT9 grown both in the presence and in the ab- 
sence of 25 pg/ml leucine. The rate of leucine uptake 
for these two strains remained derepressed even in 
the presence of high concentrations of leucine, show- 
ing that the DNA sequences remaining in the plas- 
mid pANT9 did not complement either regulatory 
mutation. Moreover, lane 4 of Figure 4 shows the 
[35S]-labeled proteins produced from E. coli minicells 
containing pANT9, and it is clear that the protein of 
M W  21,000 is not detectable. These results suggest 
that this protein corresponds to the regulatory com- 
ponent for branched-chain amino acid transport. 
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ATG GGC GTG TTC TCT TTG GTC TGG ATC TCC ATT GCC GGC GCG CAG GTA CGT CCG 
MET G l y  V a l  F'he Ser Leu V a l  T r p  l l e  Ser I l e  A l a  G l y  A l a  G l n  V a l  R r g  Pro  
8 1  I 0 8  
CGA TCA TTG CGC CGA ACA ACA GCG CGC GGT TCT TTC GCA ATA CAT AAG CAC GAA 
R r g  Ser L e u  A r g  A r g  T h r  T h r  A l a  A r g  G l y  Ser Phc A l l  I l r  Hlr Lys HIS G l u  
135 I62 
G l n  GlL I  Thr A s p  A s n  H i e  A l a  Cys H z s  Asn Thr l l e  Lys Pro Arn S-r S i r  Hi. 
CAA GAA ACA GAT AAC CAC GCC TGC CAT AAC acc ATC AAG CCG A a c  TCT TCA CAT 
189 21b 
fils T r P  C y s  T h r  C y s  G l u  C y s  As" A r g  A r g  Ser V a l  V a l  Scr Thr HI. LyS A l a  
GCT TGG TGC ACC TGC GAR TGT m c  CGA AGG TCG GTG GTT AGC ACG CAT AAA GCC 
243 270 
AGC ATA ATT CCG GCG GAT AAC AAC CCG GCA GCG TTC CCC ATG CCG M A  CTG I W T  
Ser I l e  I l e  F r o  A l a  Rsn Asn A s n  Fro A l a  A l a  Phc Pro MET Pro Lvs L-u A r n  
297 324 
GTG CTG AAC TGG AAG GTG ATC ATC CCG ATC ATC AGC CCA ATA ACA AAG AAG GCQ 
V a l  Leu A s n  T r p  L y s  V a l  I l e  I l e  Pro I l e  I l e  S P ~  Pro 11. Thr Ly. Ly. A l l  
35 1 378 
G l n  Asn A l a  Ser A r g  SPT V a l  Thr T r p  T h r  Val AS" A r q  Amp Lyr  A l a  Asp A l a  
CAG AAT GCC AGC AGG TCF, GTG ACC TGG ACT GTG AaT CGA GAT AAA GCC GAT GCG 
405 432 
ATC CAG TGT TTT TAC GCG GCG GGC ATC GTG GAT CTT GTA A I A  GGT CAC TTT GTT 
l i e  G l n  C y s  Phe T y r  A l a  A l a  Gly I l e  V a l  A s p  LPU V a l  Lys G l y  HIS Phc V a l  
459 486 
AAG CAC GAC GTT GTC ATC TAT CGG CAT CTC OAT CTG GCT AGA ATG ACG CGG TTA 
t.ys t i t s  A s p  V a l  V a l  I l e  T y r  Arg Hxs Leu Asn Leu Ala erg MET Thr  A r g  Leu 
513 
AGG A A ~  m a  CCG TGA 
A T U  I ,S ~1~ F r o  
Fig 6 Complete DNA sequence of the coding region of the lrvR gene The top line indicates DNA 
sequence and the bottom line is the translated amino acid sequence 
DNA sequencing of the regulatory region supports 
this interpretation since there is only one complete 
open reading frame within the inserted fragment from 
plasmid pANT4. Figure 6 shows the DNA sequence 
of the coding region of the liuR gene along with its 
translated protein sequence. The gene is composed of 
501 bp and encodes a protein of 166 amino acids. This 
predicted protein has a calculated MW of 19,155, 
which is in good agreement with the MW of 21,000 
observed for the regulatory protein from the minicell 
expression system. 
Figure 7 shows the amino acid sequence of the LivR 
protein and beneath are designated the predicted al- 
pha helices (A), beta sheets (B), and turns (T). It is 
possible that the carboxyl terminus of the protein 
consists of a helix-turn-helix-turn-helix conformation. 
The promoter region of the livR is presented in 
Figure 8. Three RsaI sites (5'-GTAC-3') are visible on 
this figure at positions -200, -192, and -45. From 
the expression studies carried out on the pANT4 sub- 
clone it was deduced that the entire gene and a func- 
tional promoter were encoded downstream from the 
RsaI site at -45. In this region, the only ATG fol- 
lowed by a significant open reading frame is found at  
the -2 position. There is a potential Shine-Dalgarno 
ribosome binding site26 from position - 10 to position 
-6. A strong promoter (i.e., F'ribnow box and -35 
regionY7 was detected between positions -23 and 
-55. According to the algorithm deduced by McClure 
and his associates, an ineffective promoter has a 
score of 45 or less while a very strong promoter may 
score as high as 80. With the aid of this algorithm, 
the potential promoter sequence from -23 to -55 
has a score of 66, which suggests that this is probably 
a relatively strong in vivo promoter. Another poten- 
tial promoter region is observed between positions 
-62 and - 103. Although the expression of livR from 
pANT4 indicated that this cannot be the sole pro- 
moter for liuR, its score with the McClure algorithm 
was 62, which is very similar to that of the first 
promoter. Thus, based on sequence homologies, there 
are two regions which are equally likely to drive liuR 
gene expression. 
DISCUSSION 
Previous reports on high-affinity branched-chain 
amino acid transport in E. coli revealed that two 
operons regulated by the intracellular levels of leu- 
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cine encode the protein components of the LIV-I and 
LS transport systems. Each of these operons, located 
a t  minute 76 on the E. coli chromosome, has a distinct 
cis-acting regulatory region. Moreover, independent, 
trans-acting regulatory mutations have been identi- 
fied for each transport operon. These two mutations 
(livR and IStR) were mapped to minute 20 on the E. 
coli chromosome and were not separable from each 
other genetically. 
We, therefore, attempted to clone the minute 20 
region from E. coli, and in this report we show that 
90 im 
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Fig. 7. Predicted secondary structure of the LivR protein. This 
figure shows the translated amino acid sequence and below it, 
the secondary structure predictions. The legend is as follows: A, 
alpha helix; B, beta sheet; and T, turn. Big letters indicate a strong 
propensity for that residue to conform to the predicted structure 
while small letters indicate a weaker probability for the predicted 
structure. The secondary structure predictions were generated 
by the PEP program of BioNet. This program uses the Chou and 
Fasman method. 
the gene encoding the regulatory component for high- 
affhity branched-chain amino acid transport has been 
isolated in the recombinant plasmid pANT1. Four 
subclones have been constructed and three of these 
plasrnids (pANT2, pANT3, and pANT4) complement 
the two regulatory mutations (liuR and IstR) and ex- 
press a protein with an apparent MW of 21,000. A 
fourth subcloned plasmid, pANT9, carries a deletion 
which results in no detectable expression of the pro- 
tein of M W  21,000. Concomitantly, this deletion sub- 
clone does not restore regulation of leucine transport 
in mutant strains containing either the livR or the 
lstR mutation. These data strongly suggest that the 
gene which encodes the protein of MW 21,000 is also 
the regulatory gene for high-affinity branched-chain 
amino acid transport. 
Several pieces of evidence indicate that the LivR 
protein is probably a standard prokaryotic repressor. 
The ZiuR gene is unlinked to the LIV-I and LS trans- 
port operons so that it is trans-acting; moreover, ge- 
netic studies demonstrated that the presence of 
functional LivR protein repressed the transport genes' 
expression. The size of the LivR protein is within the 
size range of other prokaryotic and phage repressors 
(MW of cro protein is 8000,30731 MW of lambda repres- 
sor is 25,000,32 and the MW of the trp repressor is 
12,500 33). The predicted secondary structure of the 
LivR protein includes a potential helix-turn-helix- 
turn-helix conformation which is common to many 
DNA-binding proteins, including repressors. How- 
ever, although it seems most likely that the LivR 
protein is a repressor, it should be noted that the 
LivR protein may also be a regulatory factor involved 
in attenuation of transport gene expression. 
It is assumed that the liv repressor utilizes a co- 
repressor, but its identity has not been determined. 
Since the liv repressor functions in response to the 
intracellular levels of leucine, one likely candidate 
for the corepressor is leucine itself. However, there is 
significant genetic evidence implicating charged leu- 
cyl-tRNA in the regulation of the rates of transport. 
In strains carrying the hisT mutation34 (pseudo-uri- 
dine in position 41 of the leucyl-tRNA) or the leuS 
(temperature sensitive leucyl-tRNA), the 
rate of branched-chain amino acid transport is consti- 
- 7 3  -220 -210 -m -190 -180 -YO -160 -150 
CGGCATGTCA TITCCTCTCT CTGCMllGT GTACAAATGT Au\u\AccTT GCTAATGllG TGllCCCTCT CrrAmGAC TGATCTATGA 
-9 -40 -50 -20 -10 BCCGTACG CCTCTATCCG 0;nTATrtrrc T C T G T C T C G A ~  ATG- LIVR GENE 
i(EGIoN? PR1m Box? 9) SITE? 
Fig. 8. Promoter sequence of the /jvR gene. Shown are 230 bp of the 5' noncoding region of the livR gene. 
A probable Shine-Dalgarno consensus site is located at - 10. There are two potential promoters (positions 
-23 to -55 and -62 to - 103). 
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tutively derepressed. Thus, another potential candi- 
date for the liv corepressor is the charged leucyl- 
tRNA. 
Interestingly, since there is enough liv repressor 
expressed in the E. coli minicells to be stained with 
Coomassie Brilliant Blue R (data not shown) and 
since the inserts of plasmids pANT1, pANT2, and 
pANT4 are oriented such that livR gene expression 
is not likely to be driven by either one of the plasmid 
promoters, this suggests that the liv repressor gene 
has a relatively strong endogenous promoter. This 
deduction is supported by the presence of potential 
tandem promoters as determined from the DNA 
sequence. 
Earlier studies have shown that leucine appears to 
play an important role in bacterial cell physiology. 
For example, in E. coli, leucine is the only branched- 
chain amino acid that serves to regulate LIV-I or LS 
transport;12 leucine is one of the amino acids to which 
bacteria exhibits ~ e n s i t i v i t y ; ~ ~  and leucine represses 
activity of several ~ p e r o n s . ~ ~ ~ ’  Leucine also has been 
shown to stimulate the expression of several operons 
in E. coli.38,4143 A detailed understanding of how 
leucine regulates its own transport activity will be 
necessary to understand its central role in the physi- 
ology of the bacterial cell. A plausible mechanism by 
which leucine may control other operons could in- 
volve the liv repressor. Studies are underway to de- 
termine its role in the regulation of leucine transport. 
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